암 프로파일링 및 패스웨이 : 기술과 세계 시장

The global market for cancer profiling and pathway technologies is expected to grow from $18.3 billion in 2025 and is projected to reach $33.9 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.2% during the forecast period of 2025 to 2030.

The North American market for cancer profiling and pathway technologies is expected to grow from $7.1 billion in 2025 and is projected to reach $13.4 billion by the end of 2030, at a CAGR of 13.6% during the forecast period of 2025 to 2030.

The European market for cancer profiling and pathway technologies is expected to grow from $4.5 billion in 2025 and is projected to reach $9.1 billion by the end of 2030, at a CAGR of 15% during the forecast period of 2025 to 2030.

Report Scope

The current report analyzes market trends in cancer profiling and pathway technologies, providing 2024 data, 2025 estimates, compound annual growth rate (CAGR) projections through 2030 (forecast period: 2025-2030), and regional markets for cancer profiling and pathway technologies. Highlights include the current and future market potential of cancer profiling and pathway technologies, as well as an analysis of the competitive environment, encompassing regulatory scenarios, drivers, restraints, and opportunities. The report also covers market shares of industry leaders.

The report provides detailed information and quantitative analysis on cancer profiling and pathway technologies used in oncology research and clinical practice. The focus is on technological platforms, tools, and services that enable the molecular profiling of tumors (both tissue-based and liquid biopsy-based) and the interpretation of results at the pathway and network levels.

The global cancer profiling and pathway technologies market is segmented by product type, profiling type, technology type, application, and geographic region.

The market is segmented into the following regions: North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. Within each region, there is an analysis of major countries, including the U.S., Canada, Mexico, Germany, the U.K., France, Italy, Spain, Japan, China, South Korea, Australia, and India. For market estimates, data is provided for the base year 2024 with forecasts for 2025 through 2030.

The report addresses the following aspects of the market:

• Types of cancer profiling and pathway technologies.
• Global market size and segmentation.
• Constraints and drivers.
• Forecasts through 2030.
• Market shares, competitiveness, and industry structure.
• Potential long-term impacts on the global cancer profiling and pathway technologies market.

Report Includes

• 146 data tables and 48 additional tables
• An analysis of the global market for cancer profiling and pathways technologies
• Analyses of the global market trends, with historic revenue (sales data) from 2022 to 2024, estimates for 2025 and projections of CAGRs through 2030
• Estimates of the current market size and revenue prospects for the global market, accompanied by a market share analysis by product type, profiling type, technology, application and region
• Facts and figures pertaining to market dynamics, technological advances, regulations, prospects and the impact of macroeconomic variables
• Insights derived from Porter's Five Forces model, as well as global supply chain analyses
• Patent review, featuring key granted and published patents
• Analysis of the industry structure, including companies' market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the current status and ESG risk ratings of leading companies
• Profiles of the leading global companies, including Illumina Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., and Exact Sciences Corp.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• Porter's Five Forces Analysis
• Bargaining Power of Buyers
• Bargaining Power of Suppliers
• Potential for New Entrants
• Threat of Substitutes
• Competitiveness in the Industry
• Macroeconomic Factor Analysis
• Healthcare Expenditure
• Demographic Shifts and Disease Burden
• Impact of U.S. Tariffs (Trade Policy and Supply Chain Risk)

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Rising Global Cancer Incidence Across Major Tumor Types
• Shift Toward Precision Oncology and Biomarker-Driven Care
• Expansion of Companion Diagnostics and Reimbursement for Molecular Tests
• Advances in Liquid Biopsy, Single-Cell, and Multi-Omics Platforms
• Market Restraints
• High Test Costs and Affordability Constraints
• Data Integration, Standardization, and Interoperability Challenges
• Shortage of Skilled Molecular and Bioinformatics Expertise
• Market Opportunities
• Development of Comprehensive Genomic and Multi-Omics Panels
• Expansion of MRD, Early Detection, and Screening Applications

Chapter 4 Regulatory Landscape

• Overview
• North America
• U.S. (FDA, CMS/CLIA)
• Europe
• Asia-Pacific
• Japan (PMDA/MHLW)
• India (CDSCO, ICMR, and National Guidelines)
• Other Asia-Pacific Regulators
• Rest of the World
• Latin America - Brazil (ANVISA)
• Middle East and Africa

Chapter 5 Emerging Technologiesand Developments

• Overview
• Ultra-High-Throughput and Long-Read Sequencing
• Single-Cell and Spatial Profiling Technologies
• High-Plex Proteomics and Multiplex IHC/Imaging Platforms
• Pipeline and Clinical Analysis
• Key Takeaways
• Pipeline Analysis
• Clinical Trials Analysis
• Clinical Trial Studies on Cancer Profiling and Pathway Technologies

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Global Cancer Profiling and Pathway Technologies Market, by Product Type
• Key Takeaways
• Reagents, Kits, and Consumables
• Instruments and Systems
• Software and Bioinformatics
• Global Cancer Profiling and Pathway Technologies Market, by Profiling Type
• Key Takeaways
• Genomic Profiling
• Transcriptomic Profiling
• Proteomic Profiling
• Epigenomic Profiling
• Multi-Omics/Integrative Profiling
• Others
• Global Cancer Profiling and Pathway Technologies Market, by Technology Type
• Key Takeaways
• Next-Generation Sequencing (NGS)
• PCR-Based Platforms
• IHC/ISH Platforms
• Flow Cytometry and Related Cytometric Platforms
• Liquid Biopsy Platforms
• Others
• Global Cancer Profiling and Pathway Technologies Market, by Application
• Key Takeaways
• Research and Biomarker Discovery
• Treatment Selection and Monitoring
• Diagnostics and Screening
• Prognostics and Risk Stratification
• Other Applications
• Geographic Breakdown
• Global Cancer Profiling and Pathway Technologies Market, by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• The Middle East and Africa

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Landscape
• Company Share Analysis
• Strategic Analysis

Chapter 8 Sustainability in Cancer Profiling and Pathway Technologies Market: An ESG Perspective

• Overview
• ESG in the Cancer Profiling and Pathway Technologies Market
• Environmental Impact
• Social Impact
• Governance Impact
• ESG Risk Ratings
• Conclusion

Chapter 9 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• 10X GENOMICS INC.
• AGILENT TECHNOLOGIES INC.
• BIO-RAD LABORATORIES INC.
• CARIS LIFE SCIENCES
• EXACT SCIENCES CORP.
• F. HOFFMANN-LA ROCHE LTD.
• FOUNDATION MEDICINE INC.
• GRAIL INC.
• GUARDANT HEALTH INC.
• ILLUMINA INC.
• NANOSTRING (BRUKER SPATIAL BIOLOGY)
• NEOGENOMICS INC.
• QIAGEN
• SYSMEX CORP.
• THERMO FISHER SCIENTIFIC INC.
• Some Emerging Companies in the Cancer Profiling and Pathway Technologies Market